General Surgery Devices Market Worth $26.5 Billion By 2026

The global general surgery devices market size is expected to reach USD 26.5 billion by 2026 registering a CAGR of 8.5%, according to a new report by Grand View Research, Inc. Increasing number of surgical procedures being performed coupled with technological advancements is anticipated to drive the market. Moreover, rising awareness and patient affordability for plastic or reconstructive surgeries would propel the number of procedures conducted during the forecast period.

Global health initiatives for the advanced surgical procedure is expected to boost the market. In January 2017, Ethiopia Federal Ministry of Health (FMOH) launched the Health Sector Transformation Plan (HSTP) and Safe Surgery (SaLTS) program that prioritizes safe surgery and makes anesthesia care and emergency surgical services accessible and affordable.

Technological advancements are also contributing to the market growth. Several key companies are investing in R&D for the development of innovative products. For instance, development of medical robots to assist surgeons is a key advancement in the field. Medical robots offer several advantages, such as a 3D view of the operating field, reduced blood loss & transfusions, lower risk of infection, faster recovery time, minimal scarring, and high precision.

Furthermore, growing aging population and cases of road accidents and increased healthcare expenditure in emerging economies are likely to boost the market during the forecast period. According to the WHO, the world’s population aged 60 years and above is expected to reach 2 billion by 2050 from 900 million in 2015. Geriatric population is more susceptible to a number of diseases, which is likely to increase the need for effective treatments, thereby driving the market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/general-surgery-devices-market

Further key findings from the study suggest:

Disposable surgical supplies held the largest market share in 2018. Low product cost and regulatory support for the usage of disposable products is expected to fuel the demand for these devices
Asia Pacific is estimated to expand at the highest CAGR over the forecast period due to technological advancements, increasing investments and improving reimbursement scenario along with the growing medical tourism sector in the region
Medical robotics & computer-assisted surgery devices are projected to witness the maximum CAGR of 9.9% from 2019 to 2026 due to increasing R&D investments and availability of technologically advanced products
Some of the key companies in the market are Medtronic plc; Johnson & Johnson Services, Inc.; CONMED Corp.; Becton, Dickinson and Company (BD); B Braun Melsungen AG; Strykers; Boston Scientific Corp.; Erbe Elektromedizin GmbH; and The 3M Company

Powered Surgical Instruments Market Size Worth $2.8 Billion By 2026

The global powered surgical instruments market size is expected to reach USD 2.8 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 3.8%. Increasing number of surgical procedures, coupled with technological advancements, is anticipated to drive the market. Moreover, increasing awareness and affordability of plastic or reconstructive surgeries and surgeries for sports injuries is likely propel growth over the forecast period.

Increase in factors such as demand for minimally invasive surgeries & robot-aided procedures as well as improving accessibility to healthcare is contributing to growth. In addition, increasing geriatric population and rising awareness about availability of surgical procedures are likely to boost the market.

Increase in number of road accidents and rising healthcare expenditure in emerging economies are other factors likely to boost revenue generation in the market. According to the U.S. Census Bureau, the global healthcare expenditure is expected to reach USD 18.28 trillion by 2040, growing at a CAGR of 2.6%. According to WHO, the global population aged 60 years and above is expected to reach 2 billion by 2050, from 900 million in 2015. This demographic is more susceptible to a vast number of diseases, increasing the need for effective treatments, thereby boosting the market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/powered-surgical-instruments-market

Further key findings from the study suggest:

North America accounted for the largest share of over 42.0%, owing to high prevalence of chronic disorders, favorable reimbursement policies, presence of key players, and government initiatives.
Asian countries are estimated to show the highest growth rate of 5% over the forecast period, due to an increasing adoption of advanced technologies, increasing investments, improving reimbursement scenario, and increasing medical tourism.
Handpiece powered surgical instruments is expected to dominate over the forecast period. It accounted for more than more than 40.0% of share in 2018.
Based on application, orthopedic, followed by cardiovascular surgery, were leading segments in the market, owing to high use of powered instruments, rising geriatric population, and growing incidence of osteoporosis and heart conditions.
Key players in powered surgical instruments market are opting for strategies, such as partnerships & acquisitions, introduction of new products, and investments in new technologies, to expand their product portfolio and to strengthen global footprint. For instance, in November 2018, Stryker Corporation announced acquisition of K2M Group Holdings, Inc., thereby expanding its product portfolio.

Ambulatory Surgery Center Market Size Worth $120.8 Billion By 2026

The global ambulatory surgery centers market size is expected to reach USD 120.8 billion by 2026, based on a new report by Grand View Research, Inc., exhibiting a 6.1% CAGR during the forecast period. Increase in incidence of chronic diseases and rise in geriatric population have furthered the demand for ambulatory surgery centers. Furthermore, advancements in surgeries, such as endoscopy and laparoscopy, are expected to propel ASC market growth.

The number of patient admissions is slowly decreasing owing to increasing outpatient visits. This is primarily due to high hospitalization cost and adoption of technologically advanced techniques in outpatient centers, making treatment fast and cost-effective. Advanced surgical methods allow tests and procedures to be performed without hospital admission. According to the American Hospital Association, the total number of outpatient admissions increased from 624 million in 2008 to 675 million in 2012. The number of inpatient admissions decreased from 35.76 million in 2008 to 34.40 million in 2012.

In May 2016, some new codes were added to the coverage for outpatient services in U.S., such as that for gynecology, adenoidectomy, and tonsillectomy. Hence, supportive reimbursement scenario is anticipated to boost market growth.

North America held the dominant share in 2018, driven primarily by U.S. Leading market players in the country are acquiring ambulatory services to provide technologically advanced surgeries and treatments, further propelling demand for ambulatory and primary care services. Asia Pacific is likely to emerge as a strong contender in the global scenario. Some of the prominent players in this region are Surgery Center of Melbourne, Nova Medical Centers, Kaiser Permanente, The Indian Association of Day Surgery, Memorial Sloan Kettering, M D Anderson Cancer Center, and The Mumbai Surgical Society.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/ambulatory-surgery-center-asc-market

Further key findings from the study suggest:

In 2018, gastroenterology accounted for the largest share in the market by application. This can be attributed to surge in visits to ambulatory care centers for treatment of gastrointestinal diseases. It is one of the most common surgical specialties in single- or multi-specialty ASCs
Plastic surgery is anticipated to observe the fastest growth in the coming years due to rise in disposable income and growing preference for private care facilities in comparison with hospital surgery centers for plastic surgery. Time and cost advantages, as well as expertise offered by these ambulatory centers, are anticipated to boost demand for plastic surgeries in these settings
North America dominated the market in 2018 thanks to increased government funding focused on transforming primary care services and rise in coverage for outpatient services
Asia Pacific is expected to witness lucrative growth in the coming years owing to presence of developing economies, increasing awareness about ASCs, and investments by international players
Key players in the market include Envision Healthcare Corporation; Terveystalo; Tenet Healthcare Corporation; MEDNAX Services, Inc.; TeamHealth, Quorum Health Corporation; UnitedHealth Group; Surgery Partners; Community Health Systems, Inc.; and Healthway Medical Group.

General Surgery Devices Market Worth $26.5 Billion By 2026

Click the link below:
https://www.grandviewresearch.com/industry-analysis/general-surgery-devices-market

Further key findings from the study suggest:

Disposable surgical supplies held the largest market share in 2018. Low product cost and regulatory support for the usage of disposable products is expected to fuel the demand for these devices
Asia Pacific is estimated to expand at the highest CAGR over the forecast period due to technological advancements, increasing investments and improving reimbursement scenario along with the growing medical tourism sector in the region
Medical robotics & computer-assisted surgery devices are projected to witness the maximum CAGR of 9.9% from 2019 to 2026 due to increasing R&D investments and availability of technologically advanced products
Some of the key companies in the market are Medtronic plc; Johnson & Johnson Services, Inc.; CONMED Corp.; Becton, Dickinson and Company (BD); B Braun Melsungen AG; Strykers; Boston Scientific Corp.; Erbe Elektromedizin GmbH; and The 3M Company